Cerence Story

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:3em;'>CRN</div>
CRNC -- USA Stock  

USD 86.63  0.09  0.10%

As many millenniums are trying to avoid technology space, it makes sense to go over Cerence a little further and try to understand its current market patterns. As expected, Cerence is starting to reaffirm its true potential as investors are becoming more and more confident in the future outlook. The returns on the market and returns on Cerence appear slightly correlated for the last few months. Weak basic indicators of the company may also suggest signs of long term losses for Cerence investors. Cerence is scheduled to announce its earnings today.
Published over a week ago
View all stories for Cerence | View All Stories
Our current technical analysis of Cerence (NASDAQ:CRNC)
This firm's average rating is Buy from 6 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Cerence market sentiment investors' perception of the future value of Cerence. Let us look at a few aspects of Cerence technical analysis.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Cerence. In general, we focus on analyzing Cerence stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cerence's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Cerence's intrinsic value. In addition to deriving basic predictive indicators for Cerence, we also check how macroeconomic factors affect Cerence price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.

How does Cerence Stands against Peers?

Analyzing Cerence competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Cerence across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Cerence Competition Details

How Cerence utilizes its cash?

To perform a cash flow analysis of Cerence, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Cerence is receiving and how much cash it distributes out in a given period. The Cerence cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Cerence Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at 79.26 Million

Sale by Ortmanns Stefan of 200 shares of Cerence

Legal trades by Cerence insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Cerence insider trading alert for sale of common stock by Ortmanns Stefan, Executive Vice President, on 12th of November 2020. This event was filed by Cerence Inc with SEC on 2020-11-12. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Closer look at Cerence Downside Variance

Cerence has current Downside Variance of 14.45. Downside Variance (or DV) is measured by target semi-variance and is termed downside volatility. It is expressed in percentages and therefore allows for rankings in the same way as variance. One way to view downside volatility is the annualized variance of returns below the target.

Downside Variance is the probability-weighted squared below-target returns. The squaring of the below-target returns has the effect of penalizing failures at an exponential rate. This is consistent with observations made on the behavior of individual decision-making under.

Downside Variance 
SUM = Summation notation
RET DEV = Actual returns deviation over selected period
N(ER) = Number of points with returns less than expected return for the period
Let's now compare Cerence Downside Variance to its closest peers:

Our perspective of the current Cerence rise

Mean deviation is down to 3.17. It may suggest a possible volatility slip. Cerence shows above-average downside volatility for the selected time horizon. We advise investors to inspect Cerence further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Cerence future alpha.

Our Conclusion on Cerence

Whereas some firms under the software?application industry are still a bit expensive, Cerence may offer a potential longer-term growth to investors. The bottom line, as of the 16th of November 2020, our analysis shows that Cerence almost neglects market trends. The company is overvalued and projects low probability of distress for the next 2 years. Our final 30 days buy-or-sell advice on the company is Strong Sell.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Cerence. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com